Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01444703
Other study ID # 332/2010
Secondary ID
Status Completed
Phase N/A
First received September 23, 2011
Last updated July 19, 2016
Start date October 2010
Est. completion date June 2011

Study information

Verified date July 2016
Source The Cleveland Clinic
Contact n/a
Is FDA regulated No
Health authority Austria: Ethikkommission
Study type Interventional

Clinical Trial Summary

The investigators propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours.


Description:

Patients will be premedicated with up to 7.5 mg p.o. midazolam, per routine. They will be told that the study involves two different solutions for prevention of post-extubation sore throat.

Patients will be randomly assigned to gargle 5 minutes before induction of general anesthesia with: 1) licorice (0.5 g); or, 2) sugar (5 g). Randomization will be based on a computer-generated table of random numbers. Licorice or sugar (placebo) will be diluted in 30 ml water and filled in a small bottle by an independent apothecary of our university. All bottles will look similar and will not be opened until just before use. Investigator and patient will be blinded to the preparation used for gargle. Patients will be asked to gargle for two minutes, but not to swallow the solution.

General anesthesia will be induced with fentanyl ≈3 µg/kg, propofol ≈1.5 mg/kg, and rocuronium ≈0.6 mg/kg. Complete muscle relaxation will be confirmed by absence of palpable twitches in response to supra-maximal train-of-four stimulation of the ulnar nerve at the wrist. The trachea will then be intubated as gentle as possible. Intubation will be attempted with a Macintosh laryngoscope, but the anesthesiologists may subsequently use any other intubation equipment as necessary. Initial tube size will be 37 cm left in women and 39 cm left for men; however, other sizes can be used if clinically necessary. Endotracheal tube cuffs will be inflated with air to 20-25 mmHg as necessary to maintain an adequate seal.

General anesthesia will be primarily be maintained with sevoflurane. Patients lungs will be ventilated with O2 in air, usually with an inspired oxygen fraction (FiO2) of ≈40%. However, additional oxygen will be provided as clinically necessary, especially during one-lung ventilation. End-tidal CO2 will be maintained between 32 and 35 mmHg as clinically practical. Deep of anesthesia will be monitored by using bispectral index BIS, kept between 40 and 50. Small amounts of opioid will be permitted during surgery and in preparation for extubation. At the end of surgery, an intercostal plexus block —using up to 20 ml Ropivacaine 0.1% — will be performed by the surgeons. 1000 mg paracetamol will be given intravenously ten minutes before end of surgery. Post operative pain will be treated with fractional piritramid (Dipidolor) 3 mg IV as required.


Recruitment information / eligibility

Status Completed
Enrollment 236
Est. completion date June 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Thoracic surgery with anticipated use of a double-lumen endotracheal tube;

- Anticipated extubation in the operating room;

- ASA Physical Status 1-3;

- Age 18- 90

Exclusion Criteria:

- Tracheal pathology, including tracheostomy;

- Surgery within the previous four weeks;

- Upper-respiratory tract infection;

- BMI higher exceeding 40 kg/m2;

- Known or suspected allergy to licorice;

- Use of non-steroidal anti-inflammatory drug medication within 24 hours;

- Chronic opioid use;

- Preoperative pain = 2 on an 11-point Likert scale (0 = no pain; 10 = worst pain);

- Known or suspected difficult airway.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care


Related Conditions & MeSH terms


Intervention

Other:
licorice solution
licorice (0.5 g)
sugar solution
sugar (5 g).

Locations

Country Name City State
Austria Universitätsklinik für Anästhesie, Intensivmedizin und Schmerztherapie an der medizinischen Universität Wien Vienna

Sponsors (1)

Lead Sponsor Collaborator
The Cleveland Clinic

Country where clinical trial is conducted

Austria, 

References & Publications (1)

Ruetzler K, Fleck M, Nabecker S, Pinter K, Landskron G, Lassnigg A, You J, Sessler DI. A randomized, double-blind comparison of licorice versus sugar-water gargle for prevention of postoperative sore throat and postextubation coughing. Anesth Analg. 2013 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary sore throat in rest after intubation We propose to test the hypothesis that pre-operative gargling with licorice reduces the incidence of sore throat in rest after intubation with double-lumen endotracheal tubes compared to placebo after surgery through the first four post-extubation hours. up to 4 hours post-extubation No
Secondary post-extubation coughing Pre-operative gargling with licorice reduces sore throat pain during the initial postoperative day. Pre-operative gargling with licorice reduces the incidence of post-extubation coughing. up to four hours post-extubation No
Secondary amount of coughing Pre-operative gargling with licorice reduces the amount of coughing during the remainder of the first postoperative day. 24 hours post operative No
Secondary sore throat in rest Pre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours first 24 hours after surgrey No
Secondary incidence of sore throat during swallowing Pre-operative gargling with licorice reduces the incidence of sore throat in rest and during swallowing within the first 24 hours first 24 hours after surgery No
See also
  Status Clinical Trial Phase
Recruiting NCT04083417 - Sore Throat in Primary Care - a Comparison of Phenoxymethylpenicillin and no Antibiotic Treatment Phase 4
Not yet recruiting NCT03517215 - The Development and Testing of a Scaling Strategy for a Community-Based Primary Care Antimicrobial Stewardship Program N/A
Not yet recruiting NCT01782183 - Thermographic Characteristics of Sore Throat by Thermographic Camera N/A
Completed NCT02608788 - S.L. Spray Solution® and Difflam® and Acular®Spray for the Prevention of Postoperative Sore Throat Phase 4
Completed NCT01986361 - Placebo-Controlled Onset-of-Action Study of Flurbiprofen Utilizing the Double-Stopwatch Method Phase 3
Completed NCT01118533 - Impact of Blades Used for Scheduled Orotracheal Intubation on Postoperative Sore Throat N/A
Completed NCT03397797 - Effect of Intraoperative Neuromuscular Blockade on Postoperative Sore Throat and Hoarseness
Completed NCT03282045 - Efficacy and Safety of the Lysobact Complete Spray®, Tantum Verde® and Pharyngal® Oromucosal Spray in the Treatment of Acute Sore Throat Phase 3
Completed NCT01902641 - Muscle Relaxation for Short Procedures N/A
Completed NCT00957996 - Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza Phase 3
Completed NCT01033799 - Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers N/A
Completed NCT05069844 - Preoperative Gum Chewing for Different Durations to Prevent Sore Throat After Endotracheal Intubation N/A
Completed NCT05247333 - Implementation of a Minor Ailment Service in Community Pharmacy Practice N/A
Recruiting NCT03369132 - Efficacy of Natural Seawater Based Throat Spray in Acute Sore Throat Relief N/A
Completed NCT02682134 - Sore Throat Prevention Following Intubation Phase 4
Terminated NCT00958776 - A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza Phase 3
Completed NCT00242281 - APC-111 MP Tablet Once a Day vs.Penicillin VK Four Times a Day Both for 10 Days in Patients With Strep Throat Phase 3
Completed NCT03729973 - Comparing Efficacy Preoperative Nebulized: Ketamine , Mgspo4 ,and Lidocaine In Attenuating Endotracheal Sore Throat Phase 3
Completed NCT04085744 - A Comparison Of Local Anesthetic Agents And Steroid On Tracheal Tube Cuff N/A
Completed NCT01506583 - Clinical Evaluation of QFlu Combo Test